Has Daniel Mankoff received payments from drug or device companies?

Yes. Drug and device makers reported $1,353 in general payments to Daniel Mankoff across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Mankoff did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Mankoff come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Mankoff

Interventional Pain Medicine · Grand Rapids, MINPI 1306803010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 65.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,194 and has fallen 97.1% since, to $35 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in MI, where the typical reported total is $2,071.

$1,353in general payments, 2019–2025

Across 34 payments — averaging $39.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$882
Medtronic$267
Nevro Corp.$78
Abbott$38
AbbVie$35
Stimwave Technologies Incorporated$20
plus $33 from 2 others

$587,868in research payments, 2019–2025

Across 41 payments — averaging $14,338 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$557K
Medtronic$31K

What the payments were for

Food & beverage$1,353100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	21	$882
Medtronic	5	$267
Nevro Corp.	2	$78
Abbott	2	$38
AbbVie	1	$35
Stimwave Technologies Incorporated	1	$20
Amgen	1	$19
GRT US Holding, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,353 in reported general payments places this provider in the 40th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan →

Other interventional pain medicine in Grand Rapids

Mary LeemputteGrand Rapids$8K
Keith JaveryGrand Rapids$3K
Marc KornGrand Rapids$3K
Stephen WinstonGrand Rapids$2K
Scott GreenwaldGrand Rapids$2K
Bennett WillardGrand Rapids$1K
Ryan PollinaSaint Clair Shores$144K
Ariel MajjhooMonroe$124K
Chad BrummettAnn Arbor$109K
Anand ThakurClinton Township$102K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →